BTK and B-cell chronic lymphocytic leukemia: Our findings suggest that a greater BCR-signaling capacity may prevail in UGT2B17HI patient cells, a notion supported by the elevated levels of phosphorylated BTK protein in UGT2B17HI CLL patient cells compared to UGT2B17LOW.